Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.445 USD | -1.57% | -10.70% | -31.19% |
15/05 | PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
10/05 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.19% | 13Cr | |
+7.15% | 11TCr | |
+11.09% | 11TCr | |
+0.70% | 2.23TCr | |
-12.30% | 2.22TCr | |
-5.61% | 1.94TCr | |
-37.85% | 1.79TCr | |
-6.04% | 1.72TCr | |
+7.87% | 1.43TCr | |
+34.95% | 1.25TCr |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- Chardan Increases Price Target on PDS Biotechnology to $16 From $15, Keeps Buy Rating